Skip to main content
. Author manuscript; available in PMC: 2011 Jun 8.
Published in final edited form as: Biochemistry. 2010 Jun 8;49(22):4583–4600. doi: 10.1021/bi100068u

Figure 4.

Figure 4

Illustration of the wild type hMC4R full agonist and partial agonist activity of the endogenous melanocortin agonists at the E61K, D90N, Y157S, and C271R hMC4Rs. The ligand efficacy is relative to non-receptor dependent maximal stimulation by the forskolin control compound which is defined as 1.0 on the Y-axis.